Mouse Anti-Human QPRT Monoclonal Antibody, Unconjugated, Clone 5D11 from ABR-Affinity BioReagents
Antibody Diluent for IHC from BD Biosciences Pharmingen
Chicken Anti-Human Quinolinate phosphoribosyltransferase Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Rabbit Anti-Human JMJD2B Polyclonal Antibody, Unconjugated from ProSci, Inc
Biology Products:(Date:12/3/2009)...ire-FirstCall/ -- Inverness Medical Innovations, I...dividuals to take charge of their health at home t...management, has declared a dividend of $3.00 per s...ed Stock ( IMA-PB). The dividend will be paid in s...al to the quotient of (a) $3.00 divided by (b) 97%...
(Date:12/2/2009)...re/ -- Reportlinker.com announces that a new marke..., Neurostimulation - A Global Market Perspecti...urostimulation---A-Global-Market-Perspective.html ...nthused by the growing base of aging population, a... as, Parkinson,s, and Alzheimer,s disease. Widespr...
(Date:12/2/2009)...swire-FirstCall/ -- Peregrine Pharmaceuticals, Inc...tient enrollment in a dose confirmation and dosime...d glioblastoma multiforme (GBM), the deadliest for...l antibody linked to a radioisotope being develope...ecifically targets cells at the center of brain tu...
(Date:12/2/2009)...cember 2 Gamida Cell announced tod...(animal study) safety and,efficacy of a gene thera...rnell Medical College and Gamida Cell. The product...h as Cooley,s Anemia. , Gamida Cell is de...vo,populations of stem/progenitor cells. The comp...
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3